Pasar al contenido principal

BIOTECNOLOGIA Y BIOFISICA DE MEMBRANAS PARA DESARROLLAR TERAPIAS INTELIGENTES INHALADAS BASADAS EN SURFACTANTE PULMONAR

PID2021-124932OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD COMPLUTENSE DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Escaping from Flatland: the role of proteins SP-B and SP-C in the formation of 3D structures in interfacial pulmonary surfactant films

  • Collada Marugán, Ainhoa
  • Carrascosa Tejedor, Javier
  • Sánchez Puga, Pablo
  • Liguori, Alessio
  • Gutfreund, Philipp
  • Santamaría, Andreas
  • Castillo Sánchez, José Carlos
  • Maestro, Armando
  • Cruz Rodríguez, Antonio
  • Pérez Gil, Jesús
Deciphering the molecular structure of pulmonary surfactant (PS) at the respiratory air-liquid interface has remained a major challenge since its discovery. This is particularly critical at minimal lung volume and surface area at the end of exhalation, when PS rapidly reorganizes into a 3D membrane network without detaching from the interfacial film, ensuring readiness and stability for subsequent respiratory cycles. Using neutron reflectometry and epifluorescence microscopy in specially designed surface balances, we have investigated the structure of model PS membranes and films at different compression stages, focusing on the key roles of the hydrophobic surfactant proteins SP-B and SP-C in the organization of the system at the interface. The structure of the studied model surfactant films (both analysed orthogonal to the interfacial plane and laterally) strongly depended on composition. We clarified the distinct roles of SP-B and SP-C, revealing that only SP-B, the only protein in surfactant that is indispensable for life, nucleates 3D membrane reservoirs beneath the interface. These findings provide mechanistic insights into how PS maintains interfacial stability during respiration, with potential implications for understanding surfactant dysfunction in respiratory diseases and for designing biomimetic surfactant replacements.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Pulmonary surfactant in asthma

  • Blanco, Odalys
  • Díaz Reyes, Mercyleidi
  • Labrada, Alexis
  • Autilio, Chiara
  • Pérez Gil, Jesús
Pulmonary surfactant is vital in human respiration. It maintains alveoli and terminal conducting airways open and therefore promotes an efficient gas exchange and low resistance in the airways during breathing dynamics. Lack or dysfunction of the pulmonary surfactant system is associated with severe lung disorders. Surfactant ability to maintain low surface tension at the respiratory air-liquid interface, with subsequent good compliance and low resistance in the airways, is extremely important for asthmatic patients. A growing series of experimental evidence indicates that surfactant dysfunction, either associated with the causes or as a consequence of asthma, can contribute to constriction of airways and exacerbation of asthma. Modulation by surfactant of the innate and induced immune response is also an important element defining propensity, but also the resolution of asthmatic crisis. Limited trials indicate that administration of exogenous therapeutic surfactant may offer favorable pharmacological effects to asthmatic patients, possibly by two different mechanisms. On the one hand, it can restore endogenous surface activity and, on the other hand, properly modulate the immune system. The objective of the present review has been to summarize and update available concepts and evidence that support the relationship between pulmonary surfactant and asthma, with particular attention to the role of pulmonary surfactant in the mechanisms of asthma manifestations as well as in the design of innovative future therapies.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Exploring protein–protein interactions and oligomerization state of pulmonary surfactant protein C (SP-C) through FRET and fluorescence self-quenching

  • Morán Lalangui, Juranny Michelle
  • Coutinho, Ana
  • Prieto, Manuel
  • Fedorov, Alexander
  • Pérez Gil, Jesús
  • Loura, Luís M. S.
  • García Álvarez, María Begoña
Pulmonary surfactant (PS) is a lipid–protein complex that forms films reducing surface tension at the alveolar air–liquid interface. Surfactant protein C (SP-C) plays a key role in rearranging the lipids at the PS surface layers during breathing. The N-terminal segment of SP-C, a lipopeptide of 35 amino acids, contains two palmitoylated cysteines, which affect the stability and structure of the molecule. The C-terminal region comprises a transmembrane α-helix that contains a ALLMG motif, supposedly analogous to a well-studied dimerization motif in glycophorin A. Previous studies have demonstrated the potential interaction between SP-C molecules using approaches such as Bimolecular Complementation assays or computational simulations. In this work, the oligomerization state of SP-C in membrane systems has been studied using fluorescence spectroscopy techniques. We have performed self-quenching and FRET assays to analyze dimerization of native palmitoylated SP-C and a non-palmitoylated recombinant version of SP-C (rSP-C) using fluorescently labeled versions of either protein reconstituted in different lipid systems mimicking pulmonary surfactant environments. Our results reveal that doubly palmitoylated native SP-C remains primarily monomeric. In contrast, non-palmitoylated recombinant SP-C exhibits dimerization, potentiated at high concentrations, especially in membranes with lipid phase separation. Therefore, palmitoylation could play a crucial role in stabilizing the monomeric α-helical conformation of SP-C. Depalmitoylation, high protein densities as a consequence of membrane compartmentalization, and other factors may all lead to the formation of protein dimers and higher-order oligomers, which could have functional implications under certain pathological conditions and contribute to membrane transformations associated with surfactant metabolism and alveolar homeostasis.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Role of N-glycosylation of surfactant protein SP-BN in lipid and SP-B interacting properties. Implications in disease

  • Isasi Campillo, Miriam
  • Rangel-Arranz, Paula
  • García Ortega, Lucía
  • Pérez Gil, Jesús
SP-BN is an independent protein derived from the precursor of pulmonary surfactant protein B (SP-B), a critical component of the pulmonary surfactant (PS), the membrane-based system that coats the alveolar air-liquid interface and is essential for both respiratory mechanics and innate defense. In humans, a single-nucleotide polymorphism (SNP) defining hSP-BN glycosylation has been associated with propensity to certain respiratory diseases, but molecular studies in this regard are scarce. Previous studies with the murine SP-BN, nonglycosylated, have suggested a role for this protein in lipid transfer during PS biogenesis. This study focuses on the structural and functional characterization of both glycosylated and nonglycosylated human SP-BN protein variants to elucidate the impact of N-glycosylation. Recombinant proteins (hSP-BN, glycosylated, and hSP-BN-T73I, nonglycosylated) were produced in Pichia pastoris and purified to homogeneity. The structural characterization confirmed the main features of hSP-BN as a member of the SAPLIP protein family: mainly α-helical, a propensity to dimerization and a high stability. Interestingly, N-glycosylation did not significantly affect hSP-BN structure. Regarding lipid interactions, both hSP-BN variants were able to bind and perturb membranes in lipid vesicles with a PS-like composition at acidic, but not neutral pH, which is relevant given the acidification during PS biogenesis. Remarkably, N-glycosylation impaired the synergistic effect of hSP-BN and mature SP-B to promote lipid mixing/transfer activity. These results support the joint action of both proteins in PS biogenesis and, more importantly, suggest that this combined activity affected with the SNP-induced glycosylation of hSP-BN could be behind certain PS defects acquired during biogenesis causing some susceptibility to respiratory diseases. NEW & NOTEWORTHY The impact of N-glycosylation on the structure and function of human SP-BN protein has been studied. Homogeneous production of glycosylated hSP-BN and nonglycosylated hSP-BN-T73I was achieved in Pichia pastoris. Structural characterization and lipid interaction properties at acidic pH revealed no significant differences due to glycosylation. N-glycosylation impairs the synergistic action of hSP-BN and SP-B in lipid transfer/mixing activity. N-glycosylation of hSP-BN could impair PS biogenesis, in agreement with its potential involvement in respiratory disease.
Docta Complutense
Publicación Artículo científico (JournalArticle)

The pristine unused pulmonary surfactant isolated from human amniotic fluid forms highly condensed interfacial films

  • Castillo Sánchez, José Carlos
  • Collada Marugán, Ainhoa
  • Batllori Badia, Emma
  • Galindo Izquierdo, Alberto
  • Cruz Rodríguez, Antonio
  • Pérez Gil, Jesús
Pulmonary surfactant is a lipid/protein complex that coats the alveolar air–liquid interface to minimize surface tension facilitating breathing mechanics. Native surfactant (NS) is typically obtained from lavages of animal lungs, where it has gone through structural alterations as a result of exposure to respiratory dynamics and highly oxidative environments. We have studied here the structure of interfacial films formed by human amniotic fluid surfactant (AFS), thought to maintain the structural and functional features of a fully operative still non-used surfactant, as it has not been subjected to breathing dynamics yet. The results show that AFS adsorbs better at the interface, to form films supporting higher compression rates, than NS upon spreading at comparable concentrations and amounts. Films formed by AFS exhibit condensed regions excluding fluorescently labeled lipids from the mere adsorption, while films formed by NS only showed segregation of ordered-like domains once subjected to compression–expansion dynamics. Finally, AFS films were consistent with the presence of solid-like highly ordered phases, while NS consisted under comparable conditions of a coexistence of liquid-disordered/liquid-ordered fluid phases. This indicates that operative surfactant films formed by freshly secreted surfactant could be much more condensed than previously supposed, likely providing maximal stability under breathing mechanics.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Effect of hydrophobic proteins in modulating the mechanical properties of lung surfactant membranes

  • Collada Marugán, Ainhoa
  • Mertens, Johann
  • Batllori Badia, Emma
  • Galindo Izquierdo, Alberto
  • Cruz Rodríguez, Antonio
  • Pérez Gil, Jesús
Pulmonary surfactant is a membranous complex that enables breathing dynamics at the respiratory surface. Extremely low values of surface tension are achieved at end-expiration thanks to a unique mixture of lipids and proteins. In particular, the hydrophobic surfactant proteins, specially the protein SP-B, are crucial for surfactant biophysical function, in order to provide the surfactant lipid matrix with the ability to form membranous multi-layered interfacial films that sustain optimal mechanical properties. To analyse the contribution of the proteins to modulate the resistance to mechanical forces of surfactant membrane-based structures, atomic force microscopy of supported lipid bilayers has been used here to determine quantitative mechanical parameters defining the effect of the presence of proteins SP-B and/or SP-C on phospholipid membranes intended to model at least part of the structures integrated into pulmonary surfactant complexes. The results show clear differences introduced by proteins in membrane thickness, lateral packing and elasticity, providing evidence supporting protein-promoted modulating of the mechanical properties of surfactant membranes. These effects are found consistent with the behaviour of two relevant native materials: whole pulmonary surfactant isolated from porcine bronchoalveolar lavages and freshly produced human pulmonary surfactant isolated from amniotic fluid, where it is transferred from the foetal lung before the respiratory air-liquid interface has been established.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Airway allergy causes alveolar macrophage death, profound alveolar disorganization and surfactant dysfunction

  • Feo-Lucas, Lidia
  • Godio, Cristina
  • Minguito de la Escalera, María
  • Álvarez Ladrón, Natalia
  • Villarrubia, Laura H.
  • Vega-Pérez, Adrián
  • González-Cintado, Leticia
  • Domínguez-Andrés, Jorge
  • García-Fojeda, Belén
  • Montero-Fernández, Carlos
  • Casals, Cristina
  • Autilio, Chiara
  • Perez-Gil, J.
  • Crainiciuc, Georgiana
  • Hidalgo, Andrés
  • López-Bravo, María
Respiratory disorders caused by allergy have been associated to bronchiolar inflammation leading to life-threatening airway narrowing. However, whether airway allergy causes alveolar dysfunction contributing to the pathology of allergic asthma remains unaddressed. To explore whether airway allergy causes alveolar dysfunction that might contribute to the pathology of allergic asthma, alveolar structural and functional alterations were analyzed during house dust mite (HDM)-induced airway allergy in mice, by flow cytometry, light and electron microscopy, monocyte transfer experiments, assessment of intra-alveolarly-located cells, analysis of alveolar macrophage regeneration in Cx3cr1 cre:R26-yfp chimeras, analysis of surfactant-associated proteins, and study of lung surfactant biophysical properties by captive bubble surfactometry. Our results demonstrate that HDM-induced airway allergic reactions caused severe alveolar dysfunction, leading to alveolar macrophage death, pneumocyte hypertrophy and surfactant dysfunction. SP-B/C proteins were reduced in allergic lung surfactant, that displayed a reduced efficiency to form surface-active films, increasing the risk of atelectasis. Original alveolar macrophages were replaced by monocyte-derived alveolar macrophages, that persisted at least two months after the resolution of allergy. Monocyte to alveolar macrophage transition occurred through an intermediate stage of pre-alveolar macrophage and was paralleled with translocation into the alveolar space, Siglec-F upregulation, and downregulation of CX3CR1. These data support that the severe respiratory disorders caused by asthmatic reactions not only result from bronchiolar inflammation, but additionally from alveolar dysfunction compromising an efficient gas exchange., This work was supported by the Ministerio de Economía y Competitividad (Grant SAF2015-69905 to CaA and Grant SAF2015-65307-R to CC), Ministerio de Ciencia e Innovación (Grants PGC2018-101899-B-100 and PID2021-122748OB-I00 to CaA, Grants RTI2018-094355‐B‐I00 and PID2021-123044OB-I00 to CC and Grant PID2021-124932OB-I00 to JP-G), and Comunidad de Madrid (Grant P2018/NMT4389 to JP-G)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Escaping from Flatland: the role of proteins SP-B and SP-C in the formation of 3D structures in interfacial pulmonary surfactant films

  • Collada, Ainhoa
  • Carrascosa-Tejedor, Javier
  • Sanchez-Puga, Pablo
  • Liguori, Alessio
  • Gutfreund, Philipp
  • Santamaria, Andreas
  • Castillo-Sánchez, José Carlos
  • Maestro, Armando
  • Cruz, Antonio
  • Pérez-Gil, Jesús
Data will be made available on request., Deciphering the molecular structure of pulmonary surfactant (PS) at the respiratory air-liquid interface has remained a major challenge since its discovery. This is particularly critical at minimal lung volume and surface area at the end of exhalation, when PS rapidly reorganizes into a 3D membrane network without detaching from the interfacial film, ensuring readiness and stability for subsequent respiratory cycles. Using neutron reflectometry and epifluorescence microscopy in specially designed surface balances, we have investigated the structure of model PS membranes and films at different compression stages, focusing on the key roles of the hydrophobic surfactant proteins SP-B and SP-C in the organization of the system at the interface. The structure of the studied model surfactant films (both analysed orthogonal to the interfacial plane and laterally) strongly depended on composition. We clarified the distinct roles of SP-B and SP-C, revealing that only SP-B, the only protein in surfactant that is indispensable for life, nucleates 3D membrane reservoirs beneath the interface. These findings provide mechanistic insights into how PS maintains interfacial stability during respiration, with potential implications for understanding surfactant dysfunction in respiratory diseases and for designing biomimetic surfactant replacements., This work has been funded by grants from the Spanish Ministry of Science and Innovation (PID2021-124932OB-I00, PID2024-156556OB-I00). We thank the Institut Laue-Langevin for the allocations of neutron beam time (doi: 10.5291/ILL-DATA.8-02-865, doi: 10.5291/ILL-DATA.8-02-891, doi: 10.5291/ILL-DATA.8-02-990, doi: 10.5291/ILL-DATA.8-02-1004) and the Partnership for Soft Condensed Matter (PSCM) for lab support., Peer reviewed
Docta Complutense
Publicación Artículo científico (JournalArticle)

Modulation of pulmonary fibrosis by pulmonary surfactant-associated phosphatidylethanolamine in vitro and in vivo

  • Tlatelpa Romero, Beatriz
  • Vázquez de Lara Cisneros, Luis G.
  • Cañadas Benito, Olga
  • Blanco Rivero, Amaya
  • Olmeda Lozano, Bárbara
  • Pérez Gil, Jesús
  • Mendoza Milla, Criselda
  • Martinez Vaquero, José Luis
  • Romero, Yair
  • Contreras Cruz, David Atahualpa
  • de la Rosa Paredes, René
  • Ruiz Salgado, Sinuhé
  • Berra Romani, Roberto
  • Collantes Gutiérrez, Alonso Antonio
  • Pérez Fernández, María Susana
  • Hernández Linares, María Guadalupe
  • Guerrero Luna, Gabriel
Pulmonary fibrosis (PF) is characterized by excessive collagen deposition and impaired lung function. Pulmonary surfactant may modulate fibroblast activity and offer therapeutic benefits. We developed a natural porcine pulmonary surfactant (NPPS) enriched with 1,2-dipalmitoyl-rac-glycero-3-phosphatidylethanolamine (PE) and evaluated its biophysical and biological properties. Biophysical analysis showed that PE improved surfactant performance by increasing surface pressure and stability. In vitro, NPPS-PE reduced collagen expression and induced apoptosis in normal human lung fibroblasts; in addition, it decreased proliferation in fibroblasts stimulated with TGF-β. In vivo, NPPS-PE improved gas exchange and significantly reduced collagen deposition in bleomycin-treated mice. These findings suggest that NPPS-PE may be a promising therapeutic strategy for fibrosing lung diseases.
Docta Complutense
Publicación Artículo científico (JournalArticle)

The role of PEGylation in the pulmonary delivery of antifibrotic liposomal therapies

  • Piñol Cancer, Marina
  • Fernández Méndez, Laura
  • Carrillo Romero, Juliana
  • Urkola Arsuaga, Ainhize
  • Azkargorta, Mikel
  • Elortza, Félix
  • Goñi de Cerio, Felipe
  • García Mouton, Cristina
  • Miranda-Pérez de Alejo, Claudia
  • Ismalaj, Ermal
  • Cañadas Benito, Olga
  • Pérez Gil, Jesús
  • Ruiz-Cabello Osuna, Jesús
  • Carregal Romero, Susana
PEGylation is commonly used to improve the pharmacokinetics and efficacy of intravenously administered drug nanocarriers; however its impact on pulmonary drug delivery remains unclear. While previous studies have focused on its role in crossing the lung mucosal barrier and stabilizing formulations for nebulization, less is known about its effects on lung surfactant corona composition, biodistribution, and therapeutic efficacy. Here, we present a multiscale study on how PEG-free and PEGylated liposomes loaded with pirfenidone interact with pulmonary barriers. PEGylation increased mucus penetration and reduced protein adsorption in the lung surfactant corona. However, statistical analysis of functional proteins showed only moderate changes in anti-inflammatory and adhesion proteins, with no apparent effect on key surfactant proteins that influence liposome fate in the lung. This correlated with similar biodistributions and retention times in both healthy and fibrotic lungs for PEG-free and PEGylated liposomes. Concerningly, PEGylated liposomes enhanced native surfactant fluidity, potentially altering lung function. In a bleomycin-induced pulmonary fibrosis model, both PEG-free and PEGylated liposomes improved the antifibrotic efficacy of pirfenidone. However, PEGylation attenuated the reduction in fibrotic biomarkers within the lung fluid. These findings suggest that, although PEGylation facilitates mucus penetration, it does not significantly enhance therapeutic outcomes and may adversely affect lung function. This study provides critical insights into the optimization of lipid-based nanocarriers for pulmonary fibrosis and other lung diseases.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Effect of hyaluronic acid on the performance of pulmonary surfactant. Towards the production of enhanced clinical surfactant formulations

  • Collada Marugán, Ainhoa
  • Blanco Rivero, Amaya
  • Cruz Rodríguez, Antonio
  • Pérez Gil, Jesús
In order to prevent alveolar collapse, the surface tension at the air-liquid interface of alveoli has to be minimized at the end of expiration. Pulmonary surfactant, a lipid-protein complex synthetized and secreted by type II pneumocytes, adsorbs into the alveolar surface to form highly surface-active interfacial films. Lack or inactivation of surfactant is associated with severe respiratory pathologies, some of them treated by supplementation with exogenous surfactant formulations. It has been demonstrated that surfactant is assembled by pneumocytes in a highly packed dehydrated state that unravels once secreted to exhibit optimal interfacial capacities. Once exposed to air and subjected to dynamic breathing, surfactant can be isolated from bronchoalveolar lavages (BAL) in more unpacked and relatively hydrated stages. In this work we have used different biophysical techniques, such as surface balances and fluorescence spectroscopy to show how BAL surfactant pre-exposed to certain polymers such as hyaluronic acid (HA) transits to a more stably packed state with improved functional capabilities that approach those of freshly secreted surfactant that had never been exposed to air, such as the surfactant that can be purified from amniotic fluid. These results open new opportunities to develop more efficient therapeutical surfactant preparations to treat respiratory pathologies still unresolved.